NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,682,075 | -21.4% | 38,013 | -13.5% | 0.04% | -25.5% |
| Q2 2023 | $2,139,288 | -27.5% | 43,964 | -17.3% | 0.05% | -34.7% |
| Q1 2023 | $2,951,832 | +126.9% | 53,167 | +64.2% | 0.07% | +94.6% |
| Q4 2022 | $1,300,865 | -41.8% | 32,384 | -36.5% | 0.04% | -44.8% |
| Q3 2022 | $2,235,000 | +60.7% | 51,014 | +30.0% | 0.07% | +48.9% |
| Q2 2022 | $1,391,000 | +452.0% | 39,247 | +1635.8% | 0.04% | +350.0% |
| Q3 2021 | $252,000 | -73.4% | 2,261 | -75.8% | 0.01% | -76.2% |
| Q1 2021 | $947,000 | -77.9% | 9,328 | -78.4% | 0.04% | -70.4% |
| Q4 2020 | $4,294,000 | +33.3% | 43,144 | -3.3% | 0.14% | +37.9% |
| Q3 2020 | $3,222,000 | -41.5% | 44,601 | -59.6% | 0.10% | -37.6% |
| Q2 2020 | $5,509,000 | +639.5% | 110,482 | +342.8% | 0.16% | +685.7% |
| Q1 2020 | $745,000 | -64.6% | 24,953 | -60.1% | 0.02% | -46.2% |
| Q4 2019 | $2,107,000 | -28.2% | 62,530 | -30.2% | 0.04% | -25.0% |
| Q3 2019 | $2,935,000 | – | 89,584 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |